Successful treatment with daratumumab for post‐HSCT refractory hemolytic anemia
Successful treatment with daratumumab for post‐HSCT refractory hemolytic anemia is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Successful treatment with daratumumab for post‐HSCT refractory hemolytic anemia have?
Successful treatment with daratumumab for post‐HSCT refractory hemolytic anemia has 45 citations in the OpenAlex counts ScholarIQ stores.
When was Successful treatment with daratumumab for post‐HSCT refractory hemolytic anemia published?
Successful treatment with daratumumab for post‐HSCT refractory hemolytic anemia has 2019 year in the ScholarIQ index.
What is the open-access status of Successful treatment with daratumumab for post‐HSCT refractory hemolytic anemia?
Successful treatment with daratumumab for post‐HSCT refractory hemolytic anemia has closed oa status in the ScholarIQ index.
What is the DOI of Successful treatment with daratumumab for post‐HSCT refractory hemolytic anemia?
The DOI for Successful treatment with daratumumab for post‐HSCT refractory hemolytic anemia is on the source record.
What is the PMID of Successful treatment with daratumumab for post‐HSCT refractory hemolytic anemia?
The PMID for Successful treatment with daratumumab for post‐HSCT refractory hemolytic anemia is on the source record.
What is the OpenAlex record for Successful treatment with daratumumab for post‐HSCT refractory hemolytic anemia?
The OpenAlex for Successful treatment with daratumumab for post‐HSCT refractory hemolytic anemia is on the source record.